DK0462194T3 - Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger - Google Patents

Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger

Info

Publication number: DK0462194T3
Authority: DK; Denmark
Prior art keywords: fgf; growth factor; fibroblast growth; stabilized compositions; tissular
Prior art date: 1989-03-09

Application number

DK90904852.2T

Other languages

English (en)

Inventor

Denis Barritault

Jacqueline Jozefonvicz

Faouzi Slaoui

Michele Tardieu

Jean-Pierre Caruelle

Jose Courty

Original Assignee

Therapeutiques Substitutives

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-09

Filing date

1990-03-09

Publication date

1994-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0462194(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-03-09 Application filed by Therapeutiques Substitutives filed Critical Therapeutiques Substitutives

1994-09-19 Application granted granted Critical

1994-09-19 Publication of DK0462194T3 publication Critical patent/DK0462194T3/da

Links

102000018233 Fibroblast Growth Factor Human genes 0.000 title abstract 3
108050007372 Fibroblast Growth Factor Proteins 0.000 title abstract 3
229940126864 fibroblast growth factor Drugs 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
230000001413 cellular effect Effects 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
229920002307 Dextran Polymers 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000001172 regenerating effect Effects 0.000 abstract 1
230000008929 regeneration Effects 0.000 abstract 1
238000011069 regeneration method Methods 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

DK90904852.2T 1989-03-09 1990-03-09 Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger DK0462194T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8903086A FR2644066B1 (fr)	1989-03-09	1989-03-09	Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Publications (1)

Publication Number	Publication Date
DK0462194T3 true DK0462194T3 (da)	1994-09-19

Family

ID=9379523

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90904852.2T DK0462194T3 (da)	1989-03-09	1990-03-09	Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger

Country Status (10)

Country	Link
EP (1)	EP0462194B1 (da)
JP (1)	JP3236916B2 (da)
AT (1)	ATE106743T1 (da)
AU (1)	AU5283890A (da)
CA (1)	CA2048638C (da)
DE (1)	DE69009748T2 (da)
DK (1)	DK0462194T3 (da)
ES (1)	ES2057544T3 (da)
FR (1)	FR2644066B1 (da)
WO (1)	WO1990010456A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5202311A (en) *	1988-08-19	1993-04-13	Children's Medical Center Corporation	Stabilized fgf composition
US5482929A (en) *	1991-12-26	1996-01-09	Kaken Pharmaceutical Co., Ltd.	Composition of stabilized fibroblast growth factor
FR2718024B1 (fr) *	1994-03-30	1996-06-21	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2718025B1 (fr) *	1994-03-30	1996-06-21	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
FR2718026B1 (fr) *	1994-03-30	1997-01-17	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement des muscles.
FR2718023B1 (fr) *	1994-03-30	1996-08-14	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
FR2772382B1 (fr) *	1997-12-11	2000-03-03	Solutions	Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2781485B1 (fr)	1998-07-21	2003-08-08	Denis Barritault	Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2781375A1 (fr) *	1998-07-21	2000-01-28	Denis Barritault	Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
DE69936212T2 (de) *	1998-09-04	2008-01-24	Scios Inc., Sunnyvale	Hydrogelzusammensetzungen mit kontrollierter Freigabe für die Verabreichung von Wachstumsfaktoren
FR2794649B1 (fr) *	1999-06-11	2003-04-11	Solutions	Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) *	1999-06-16	2004-05-07	Solutions	Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
US8846003B2 (en)	2008-03-27	2014-09-30	Symic Biomedical, Inc.	Collagen-binding synthetic peptidoglycans, preparation, and methods of use
EP2714718B1 (en)	2011-05-24	2017-01-11	Symic IP, LLC	Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
BR112015022917A2 (pt)	2013-03-15	2017-07-18	Symic Biomedical Inc	peptidoglicanos sintéticos componentes da matriz extracelular
US10772931B2 (en)	2014-04-25	2020-09-15	Purdue Research Foundation	Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10792106B2 (en)	2016-10-28	2020-10-06	Covidien Lp	System for calibrating an electromagnetic navigation system
EP3648774A4 (en)	2017-07-07	2021-04-21	Symic IP, LLC	SYNTHETIC ORGANIC CONJUGATES
US11596399B2 (en)	2021-06-23	2023-03-07	Covidien Lp	Anvil buttress attachment for surgical stapling apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ222413A (en) *	1986-11-05	1991-06-25	Ethicon Inc	Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser

1989
- 1989-03-09 FR FR8903086A patent/FR2644066B1/fr not_active Expired - Fee Related
1990
- 1990-03-09 JP JP50494990A patent/JP3236916B2/ja not_active Expired - Lifetime
- 1990-03-09 EP EP90904852A patent/EP0462194B1/fr not_active Expired - Lifetime
- 1990-03-09 DE DE69009748T patent/DE69009748T2/de not_active Expired - Lifetime
- 1990-03-09 WO PCT/FR1990/000164 patent/WO1990010456A1/fr not_active Ceased
- 1990-03-09 DK DK90904852.2T patent/DK0462194T3/da active
- 1990-03-09 AU AU52838/90A patent/AU5283890A/en not_active Abandoned
- 1990-03-09 CA CA002048638A patent/CA2048638C/en not_active Expired - Lifetime
- 1990-03-09 AT AT90904852T patent/ATE106743T1/de not_active IP Right Cessation
- 1990-03-09 ES ES90904852T patent/ES2057544T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
FR2644066B1 (fr)	1994-05-13
ES2057544T3 (es)	1994-10-16
DE69009748D1 (de)	1994-07-14
CA2048638C (en)	2002-06-11
AU5283890A (en)	1990-10-09
DE69009748T2 (de)	1994-09-22
FR2644066A1 (fr)	1990-09-14
EP0462194B1 (fr)	1994-06-08
JP3236916B2 (ja)	2001-12-10
EP0462194A1 (fr)	1991-12-27
CA2048638A1 (en)	1990-09-10
ATE106743T1 (de)	1994-06-15
WO1990010456A1 (fr)	1990-09-20
JPH04505756A (ja)	1992-10-08

Publication	Publication Date	Title
DE69009748D1 (de)	1994-07-14	Fgf enthaltende stabilisierte zubereitungen.
DE3874813D1 (de)	1992-10-29	Zusammensetzung zur behandlung der haut.
EP0202298A4 (en)	1988-07-04	MEDICINE FOR Wounds.
ATE469654T1 (de)	2010-06-15	Verwendung des erythropoietins zur regeneration von lebergewebe
BRPI9908182C1 (pt)	2021-05-25	composições de proteína de matriz para cura de feridas
PT1019040E (pt)	2005-01-31	Inibicao da actividade de p38-quinase por meio de arilureias
GR3025596T3 (en)	1998-03-31	Compositions and methods for identifying biologically active molecules.
EE9700225A (et)	1998-02-16	Meetod diabetes mellituse raviks, kasutades KKF
ATE435030T1 (de)	2009-07-15	Heilung von wunden oder fibrotischen krankheiten unter verwendung von wenigstens einem agens gegen einen wachstumsfaktor
ATE96329T1 (de)	1993-11-15	Topisch anwendbare pharmazeutische zubereitung.
ATE219061T1 (de)	2002-06-15	Huperzin a analoge verbindungen
PT809437E (pt)	2005-05-31	Tiois para promover crescimento de celulas progenitoras hematopoieticas
DE60035133D1 (de)	2007-07-19	Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ATE345809T1 (de)	2006-12-15	Arzneimittelzusammensetzung enthaltend tcf-ii
DE69814691D1 (de)	2003-06-18	Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
TR199802706T2 (xx)	1999-05-21	Bir bitki hastal��n�n iyile�tirilmesi i�in y�ntem.
ES8801624A1 (es)	1988-02-16	Procedimiento para preparar disulfuros heterociclicos
DE69113049D1 (de)	1995-10-19	Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
DE69008282D1 (de)	1994-05-26	Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
UA15363A (uk)	1997-06-30	Засіб для лікуваhhя відкритих пошкоджеhь
UA10281C2 (uk)	2000-11-15	Спосіб отримання речовини для лікування захворювань підшлункової залози